Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1988 Oct;41(10):1114–1116. doi: 10.1136/jcp.41.10.1114

Low serum haemolytic function of the fourth complement component (C4) in insulin dependent diabetes.

G Senaldi 1, B A Millward 1, M J Hussain 1, D A Pyke 1, R D Leslie 1, D Vergani 1
PMCID: PMC1141698  PMID: 3192734

Abstract

Low serum concentrations of the fourth component of complement (C4) are found in insulin dependent diabetes, and may be important in the aetiology of the disease. To ascertain whether function of C4 is also impaired both its haemolytic activity and its concentration were measured in 34 insulin dependent diabetics, 15 non-insulin dependent diabetics, 20 healthy subjects, and 12 pairs of monozygotic twins discordant for insulin dependent diabetes. C4 function was measured by a radial immune haemolytic assay, and C4 concentration by laser nephelometry. Both measurements were significantly lower in insulin dependent diabetics (C4 function: median 47%, range 4-100%; C4 concentration: 0.22 g/l, 0.10-0.38 g/l) than in non-insulin dependent diabetics (67%, 33-138%, p less than 0.01; 0.27 g/l, 0.16-0.50 g/l, p less than 0.02) and controls (74%, 33-138%, p less than 0.01; 0.27 g/l, 0.18-0.40 g/l, p less than 0.03). C4 function and concentration were lower in both diabetic (48%, 12-100%; 0.17 g/l, 0.08-0.31 g/l) and non-diabetic twins (47%, 12-100%; 0.17 g/l, 0.07-0.36 g/l) than controls (p less than 0.01; p less than 0.01). Thirteen (38%) of the insulin dependent diabetics had a reduction in either C4 function or concentration, but in only five were both features reduced. Values of function and concentration were strongly correlated in both diabetic and non-diabetic twins (r = 0.95, p less than 0.001; r = 0.92, p less than 0.001). These results show defects in C4 function and concentration in insulin dependent diabetes, which--being present in the non-diabetic co-twin of diabetics--may represent a genetic predisposition to the disease.

Full text

PDF
1114

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awdeh Z. L., Alper C. A. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3576–3580. doi: 10.1073/pnas.77.6.3576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnett A. H., Eff C., Leslie R. D., Pyke D. A. Diabetes in identical twins. A study of 200 pairs. Diabetologia. 1981 Feb;20(2):87–93. doi: 10.1007/BF00262007. [DOI] [PubMed] [Google Scholar]
  3. Barnett A. H., Mijovic C., Fletcher J., Chesner I., Kulkuska-Langlands B. M., Holder R., Bradwell A. R. Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes. Br Med J (Clin Res Ed) 1984 Oct 13;289(6450):943–945. doi: 10.1136/bmj.289.6450.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bunn H. F. Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med. 1981 Feb;70(2):325–330. doi: 10.1016/0002-9343(81)90769-5. [DOI] [PubMed] [Google Scholar]
  5. Carroll M. C., Alper C. A. Polymorphism and molecular genetics of human C4. Br Med Bull. 1987 Jan;43(1):50–65. doi: 10.1093/oxfordjournals.bmb.a072176. [DOI] [PubMed] [Google Scholar]
  6. Cooper M. E., Duff R., Buchanan R., McPherson J., Jerums G. Low serum C4 concentrations and microangiopathy in type I and type II diabetes. Br Med J (Clin Res Ed) 1986 Mar 22;292(6523):801–801. doi: 10.1136/bmj.292.6523.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cudworth A. G., Woodrow J. C. Evidence for HL-A-linked genes in "juvenile" diabetes mellitus. Br Med J. 1975 Jul 19;3(5976):133–135. doi: 10.1136/bmj.3.5976.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Daniels C. A., Borsos T., Rapp H. J., Snyderman R., Notkins A. L. Neutralization of sensitized virus by the fourth component of complement. Science. 1969 Aug 1;165(3892):508–509. doi: 10.1126/science.165.3892.508. [DOI] [PubMed] [Google Scholar]
  9. Jacob B. G., Richter W. O., Schwandt P., Fateh-Moghadam A., Witt T. N. Low serum C4 concentrations and peripheral neuropathy in type I and type II diabetes. Br Med J (Clin Res Ed) 1986 Jun 21;292(6536):1671–1671. doi: 10.1136/bmj.292.6536.1671-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McCluskey J., McCann V. J., Kay P. H., Zilko P. J., Christiansen F. T., O'Neill G. J., Dawkins R. L. HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia. 1983 Mar;24(3):162–165. doi: 10.1007/BF00250155. [DOI] [PubMed] [Google Scholar]
  11. O'Neill G. J., Yang S. Y., Dupont B. Two HLA-linked loci controlling the fourth component of human complement. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5165–5169. doi: 10.1073/pnas.75.10.5165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rich S., O'Neill G., Dalmasso A. P., Nerl C., Barbosa J. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes. Diabetes. 1985 May;34(5):504–509. doi: 10.2337/diab.34.5.504. [DOI] [PubMed] [Google Scholar]
  13. Senaldi G., Millward B. A., Hussein M. J., Pyke D., Leslie R. D., Vergani D. Complement in type 1 (insulin-dependent) diabetes. Diabetologia. 1987 Oct;30(10):823–823. doi: 10.1007/BF00275751. [DOI] [PubMed] [Google Scholar]
  14. Vergani D., Johnston C., B-Abdullah N., Barnett A. H. Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes? Br Med J (Clin Res Ed) 1983 Mar 19;286(6369):926–928. doi: 10.1136/bmj.286.6369.926. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES